Many different types of drugs can be used to treat multiple myeloma. Learn more about them here.
Abstract ; Background : Belantamab mafodotin had single-agent activity in patients with relapsed or refractory multiple myeloma, a finding that supports further evaluation of the agent in combination with standard-care therapies. Results : In total, 494 patients were randomly assigned to receive BVd (243 patients) or DVd (251 patients). At a median follow-up of 28.2 months (range, 0.1 to 40.0), median progression-free survival was 36.6 months (95% confidence interval [CI], 28.4 to not reached) i...
Antibody-drug conjugates are a new kind of targeted treatment for multiple myeloma . They deliver powerful cancer-killing drugs straight to myeloma cells, and they help your own immune system attack the cancer. It's a more precise way to treat your cancer with medicine without harming healthy cells. Multiple myeloma has become easier to treat thanks to new medications, but it's still not curable. Over time, the cancer often becomes resistant to treatment. Each new treatment produces a shorter an...
Multiple myeloma Other names Plasma cell myeloma, myelomatosis, Kahler's disease, myeloma [1]... [18] It is difficult to judge mortality statistics because treatments for the disease are...
Compare risks and benefits of common medications used for Multiple Myeloma. Find the most popular drugs, view ratings and user reviews.
Abstract ; Background : Daratumumab, a monoclonal antibody targeting CD38, has been approved for use with standard myeloma regimens. An evaluation of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone (VRd) for the treatment of transplantation-eligible patients with newly diagnosed multiple myeloma is needed. Results : At a median follow-up of 47.5 months, the risk of disease progression or death in the D-VRd group was lower than the risk in the VRd group. The est...
The Ministry of Food and Drug Safety approved the orphan drug Tecvayli (ingredient: teclistamab) for the treatment of multiple myeloma on July 26.Multiple myeloma is a type of blood cancer...
Multiple myeloma compromises the immune system, which can cause opportunistic infections. Learn about prescription drugs that can help improve immune system performance.
Your doctor might recommend chemotherapy drugs for a few different reasons when you get treatment for multiple myeloma. Here’s what you need to know.
The Ministry of Food and Drug Safety (MFDS) said on Thursday that it has approved an orphan drug Elrexfio (elranatamab), imported by Pfizer Korea. The drug is indicated as monotherapy in adult patients with relapsed or refractory multiple myeloma who have received three or more prior therapies, including proteasome inhibitors, immunomodulatory agents, and anti-CD38 monoclonal antibodies. Elrexfio destroys multiple myeloma cancer cells in an immune response by targeting B-cell maturation antigen ...